Bruckental I, Huntington G B, Baer C K, Erdman R A
Department of Animal Sciences, University of Maryland, College Park 20742, USA.
J Anim Sci. 1997 Apr;75(4):1119-29. doi: 10.2527/1997.7541119x.
Six Holstein steers, 6 mo of age, with a BW range of 180 to 200 kg were used to determine effects of abomasal casein infusion and recombinant bovine somatotropin on amino acid absorption and metabolism in the gut and liver. Catheters were positioned in the hepatic vein, the hepatic portal vein, two mesenteric veins, and a mesenteric artery. Using the same basal diet, treatments consisted of 1) basal diet only (Control), 2) abomasal casein infusion of 300 g/d (Casein), and 3) abomasal casein infusion plus daily injection of 20 mg of bovine somatotropin (ST). All steers were fed the basal diet at a rate of 24 g/kg of BW on a DM basis, in 12 equal meals at 2-h intervals. Initially, Casein and ST treatments were in a balanced cross-over design, and then all steers received the Control treatment. Casein infusion tended to increase BW gain but did not affect BW gain per unit of N intake. The ST treatment increased weight gain (P < .01) and efficiency of dietary DM (P < .01) and N (P < .01) utilization by more than 40% and increased the percentage of absorbed N retained. Nonessential, essential, and total amino acid fluxes in portal-drained viscera (PDV) and their net removal by the liver were not affected by casein infusion. However, ST tended to reduce PDV flux of essential, nonessential, and total amino acids by approximately 30%, and their removal by the liver (P < .08). As a result, ST increased, compared with casein, release of essential (P < .06) and total (P < .10) amino acids from the total splanchnic pool (TSP) into peripheral blood. The ST treatment increased the availability of absorbed amino acids to peripheral tissues, but it did not affect the amino acid profile delivered from splanchnic tissues, especially that of essential amino acids.
选用6头6月龄、体重在180至200千克之间的荷斯坦公牛,以确定皱胃灌注酪蛋白和重组牛生长激素对肠道和肝脏中氨基酸吸收及代谢的影响。将导管分别置于肝静脉、肝门静脉、两条肠系膜静脉和一条肠系膜动脉中。采用相同的基础日粮,处理方式包括:1)仅基础日粮(对照组);2)每天皱胃灌注300克酪蛋白(酪蛋白组);3)皱胃灌注酪蛋白并每天注射20毫克牛生长激素(生长激素组)。所有公牛均按每千克体重24克干物质的日粮基础量,分12次等量投喂,间隔2小时。起初,酪蛋白组和生长激素组采用平衡交叉设计,之后所有公牛均接受对照组处理。酪蛋白灌注有增加体重的趋势,但不影响每单位氮摄入量的体重增加量。生长激素组使体重增加(P < 0.01),日粮干物质(P < 0.01)和氮(P < 0.01)的利用率提高了40%以上,并增加了吸收氮的保留百分比。皱胃灌注酪蛋白不影响门静脉引流内脏(PDV)中必需氨基酸、非必需氨基酸和总氨基酸通量以及肝脏对它们的净清除率。然而,生长激素组有使PDV中必需氨基酸、非必需氨基酸和总氨基酸通量降低约30%的趋势,同时肝脏对它们的清除率也降低(P < .08)。结果,与酪蛋白组相比,生长激素组使必需氨基酸(P < .06)和总氨基酸(P < .10)从总内脏池(TSP)释放到外周血中的量增加。生长激素组提高了外周组织吸收氨基酸的可用性,但不影响内脏组织输送的氨基酸谱,尤其是必需氨基酸谱。